KIWA BIO-TECH PRODUCTS GROUP CORP: 10-Q filed 2013-11-14
What KIWA BIO-TECH PRODUCTS GROUP CORP reported in its quarterly report filed 2013-11-14 (fiscal Q3 2013): 25 published measures, 74 facts as tagged in accession 0001144204-13-061404.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-11-14
- Fiscal period
- fiscal Q3 2013
- Accession
- 0001144204-13-061404 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KIWA BIO-TECH PRODUCTS GROUP CORP filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 29,385 | USD | |
| At 2012-12-31 | 42,046 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 10,091,866 | USD | |
| At 2012-12-31 | 13,848,327 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | -10,062,481 | USD | |
| At 2012-12-31 | -13,806,281 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 4,625 | USD | |
| At 2012-12-31 | 4,493 | USD | |
| At 2012-09-30 | 13,638 | USD | |
| At 2011-12-31 | 16,307 | USD |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | -106,641 | USD | 273 |
| 2012-01-01 to 2012-09-30 | -217,424 | USD | 274 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 0 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 0 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 0 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 0 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 108,938 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 203,611 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | -17,829,281 | USD | |
| At 2012-12-31 | -21,704,464 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 0 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 0 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 0 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 0 | USD | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 12,927 | USD | |
| At 2012-12-31 | 15,965 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -309,838 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -897,405 | USD | 273 |
| 2012-07-01 to 2012-09-30 | -301,726 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -871,082 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 16,458 | USD | |
| At 2012-12-31 | 26,081 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 57,656 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 181,292 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 63,602 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 189,926 | USD | 274 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 8,212,781 | USD | |
| At 2012-12-31 | 12,002,449 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 309,838 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 897,405 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 301,726 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 871,082 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 40,907 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 121,702 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 39,765 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 119,019 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 400,000,000 | shares | |
| At 2012-12-31 | 400,000,000 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | -726,537 | USD | |
| At 2012-12-31 | -595,154 | USD |
Net deferred tax assets
Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 0 | USD | |
| At 2012-12-31 | 0 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 4,586,386 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 3,875,183 | USD | 273 |
| 2012-07-01 to 2012-09-30 | -252,310 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -947,990 | USD | 274 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 4,586,386 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 3,875,183 | USD | 273 |
| 2012-07-01 to 2012-09-30 | -252,310 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -947,990 | USD | 274 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 4,564,927 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 3,743,800 | USD | 273 |
| 2012-07-01 to 2012-09-30 | -325,167 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -1,004,393 | USD | 274 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 268,931 | USD | 92 |
| 2013-04-01 to 2013-09-30 | 325,351 | USD | 183 |
| 2013-01-01 to 2013-09-30 | 775,703 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 261,961 | USD | 92 |
| 2012-04-01 to 2012-09-30 | 295,978 | USD | 183 |
| 2012-01-01 to 2012-09-30 | 752,063 | USD | 274 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 3,325 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 3,735 | USD | 274 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 0 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 0 | USD | 274 |
Inspect the source
- Entity
- KIWA BIO-TECH PRODUCTS GROUP CORP / CIK 0001159275
- Captured
- SEC response SHA-256
074c7ef0a833d858f3545ca8e68cbd9838b9689e73d55bfdb4b8ce50c68f0c88
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001159275.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))